|
Market Cap (5-Jun) $13,719,451 (1,617th) |
Close (30-Jun) $0.075 |
Volume (30-Jun) 431,146 |
Shortsold (21-Jul) 380,000 (0.14%) (384th) |
|
52w High $0.098 |
52w Low $0.026 |
P/E - |
EPS -0.02 |
IMC released this announcement to the ASX on 30 May 2023, 14:02. The announcement is marked as price sensitive, and is 3 page(s) in length and 297.14kb in size.
You can view all announcements from IMC and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMC was 0.008% short sold according to ASIC data. It was ranked the 558th most shorted stock on the ASX. It is now ranked as the 384th most shorted stock on the ASX with 0.142% of total shares short sold as of the latest reported data (21 July 2025).
| Other Recent Announcements from IMC | |
|---|---|
| Immuron Chairman Transition | 30 June 2023, 11:03 |
| Letter to Shareholders | 22 June 2023, 8:27 |
| Immuron CEO, Steven Lydeamore presents at LD Micro | 7 June 2023, 8:26 |
| Immuron Initiates Recruitment of Travelan Clinical Study | 30 May 2023, 14:02 |
| FDA Removed Clinical Hold on Campylobacter ETEC Therapeutic | 8 May 2023, 8:58 |
| IMC CEO Steven Lydeamore to present at Coffee Microcaps | 2 May 2023, 8:17 |
| Q3 FY23 Business Update Presentation | 19 April 2023, 9:15 |
You must be logged in to post a reply.
Immuron 